Friday's U.S. Supreme Court decision that found there is no constitutional right to abortion will likely lead to a boost in over-the-counter (OTC) contraceptives, especially benefitting Perrigo (NYSE:PRGO), according to Raymond James. "There is simply no company that could benefit more than PRGO from a potential shift towards more accessible contraception options that could be catalyzed by the ...